Diagnostic tool for Glanzmann's thrombasthenia clinicopathologic spectrum
- PMID: 18454893
Diagnostic tool for Glanzmann's thrombasthenia clinicopathologic spectrum
Abstract
Objective: To platelet aggregometry and describe the clinical spectrum of Glanzmann's thrombasthenia diagnosed by platelet aggregometry.
Study design: A case-series.
Place and duration of study: This study was carried out at the clinical laboratories at the Aga Khan University Hospital, Karachi from January 2003 to January 2006.
Patients and methods: All patients irrespective of age and gender presenting with bleeding symptoms and having normal platelet count were evaluated. Demographic details, relevant clinical history along with results of complete blood count, bleeding time and platelet aggregation studies were retrieved through computerized data base and evaluated for the diagnosis of Glanzmann's thrombasthenia.
Results: During the study period, 50 out of 2317 patients (2.2%) were diagnosed as Glanzmann's thrombasthenia by platelet aggregometry with male to female ratio of 0.85:1 and median age of 10.2 years (ranging from 3 months to 27 years). Common symptoms were epistaxis, oral and gingival bleed, bleeding from minor cuts and trauma that were observed in 46% of the patients; while 18%, 8% and 10% of them also complained of bruising, hematuria and bleeding per rectum respectively. Majority i.e. 86% had a bleeding time greater than 10 minutes. All patients had received blood or blood products for their bleeding episodes.
Conclusion: Platelet aggregometry is a useful diagnostic modality for the assessment of Glanzmann's thrombasthenia. The disorder presents with muco-cutaneous bleeding and was found to be a common cause of bleeding in our setup.
Similar articles
-
Clinical spectrum of Glanzmann's thrombasthenia.Indian J Pathol Microbiol. 2000 Jul;43(3):297-302. Indian J Pathol Microbiol. 2000. PMID: 11218676
-
Glanzmann Thrombasthenia: A Clinicopathological Profile.J Coll Physicians Surg Pak. 2016 Aug;26(8):647-50. J Coll Physicians Surg Pak. 2016. PMID: 27539755
-
Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.Platelets. 2011;22(5):321-7. doi: 10.3109/09537104.2011.556275. Epub 2011 Apr 28. Platelets. 2011. PMID: 21526886
-
Glanzmann's thrombasthenia: updated.Platelets. 2002 Nov;13(7):387-93. doi: 10.1080/0953710021000024394. Platelets. 2002. PMID: 12487785 Review.
-
Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder.Br J Haematol. 2004 Oct;127(2):209-13. doi: 10.1111/j.1365-2141.2004.05173.x. Br J Haematol. 2004. PMID: 15461628 Review.
Cited by
-
Bleeding Phenotype of Glanzmann Thrombasthenia (GT) and Treatment Outcomes in Over One Hundred Patients: A Two-Center Experience in North Pakistan.Cureus. 2024 Nov 15;16(11):e73724. doi: 10.7759/cureus.73724. eCollection 2024 Nov. Cureus. 2024. PMID: 39677151 Free PMC article.
-
[Glanzmann thrombasthenia: about 11 cases].Pan Afr Med J. 2015 Aug 11;21:268. doi: 10.11604/pamj.2015.21.268.6502. eCollection 2015. Pan Afr Med J. 2015. PMID: 26587119 Free PMC article. French.
-
Genetic Confirmation and Identification of Novel Variants for Glanzmann Thrombasthenia and Other Inherited Platelet Function Disorders: A Study by the Korean Pediatric Hematology Oncology Group (KPHOG).Genes (Basel). 2021 May 6;12(5):693. doi: 10.3390/genes12050693. Genes (Basel). 2021. PMID: 34066320 Free PMC article.
-
Simultaneous occurrence of intussusception and duodenal haematoma in a patient with Glanzmann's thrombasthenia.Afr J Paediatr Surg. 2016 Oct-Dec;13(4):202-205. doi: 10.4103/0189-6725.194676. Afr J Paediatr Surg. 2016. PMID: 28051053 Free PMC article.
MeSH terms
LinkOut - more resources
Research Materials
Miscellaneous